Market revenue in 2024 | USD 2,901.2 million |
Market revenue in 2030 | USD 3,058.9 million |
Growth rate | 1.2% (CAGR from 2025 to 2030) |
Largest segment | Antivirals |
Fastest growing segment | Antifungals |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antibacterials, Antivirals, Antifungals |
Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 59.85% in 2024. Horizon Databook has segmented the Brazil anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
In July 2024, GSK plc, in collaboration with Medicines for Malaria Venture (MMV), launched tafenoquine, the first single-dose medication designed to prevent the relapse of Plasmodium vivax malaria. Co-administered with chloroquine for radical cure, this breakthrough is a crucial step in Brazil’s efforts to eliminate malaria.
The introduction of such innovative treatments reflects a broader commitment to addressing infectious diseases in the country. With ongoing research and development efforts supported by government initiatives, Brazil is positioned to enhance its capabilities in combating various infectious diseases effectively.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil anti-infective agents market , including forecasts for subscribers. This country databook contains high-level insights into Brazil anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account